Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab
Clinical trial NCT03707808 · RECRUITING
Trial details
- NCT number
- NCT03707808
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2025-12-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.